BSPTS and Core Stabilization Exercises in Adolescents With Idiopathic Scoliosis

August 8, 2026 updated by: Yunus Emre Tutuneken, Istinye University

Effects of Core Stabilization Exercises Combined With Barcelona Scoliosis Physical Therapy School Exercises on Trunk Rotation Angle and Core Muscle Endurance in Individuals With Adolescent Idiopathic Scoliosis: A Randomized Controlled Study

This study aims to investigate the short-term effects of adding core stabilization exercises to Barcelona Scoliosis Physical Therapy School (BSPTS) exercises in adolescents with idiopathic scoliosis. Participants will be randomly assigned to either a BSPTS exercise group or a BSPTS plus core stabilization exercise group. Both groups will participate in supervised exercise sessions twice a week for 6 weeks. The study will evaluate changes in trunk rotation angle and core muscle endurance as the primary outcomes, as well as dynamic balance, spinal appearance perception, postural awareness, and scoliosis-related quality of life.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
36

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of adolescent idiopathic scoliosis.
  • Cobb angle between 10° and 40°.
  • Risser sign between 0 and 3.
  • Ability to understand and perform the exercise instructions.
  • Willingness to participate in the study and provision of informed consent.

Exclusion Criteria:

  • Scoliosis associated with congenital, neuromuscular, or syndromic conditions.
  • Previous spinal surgery.
  • Presence of significant lower-extremity deformity or neurological disorder affecting balance or exercise performance.
  • Current participation in another scoliosis-specific exercise program.
  • Severe cardiopulmonary or systemic disease contraindicating exercise.
  • Inability to complete the assessment procedures or exercise program.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: BSPTS Plus Core Stabilization Exercise Group
Other: BSPTS Plus Core Stabilization Exercise
Participants will receive the same BSPTS-based scoliosis-specific exercise program, combined with core stabilization exercises targeting activation of the transversus abdominis, multifidus, and other deep trunk muscles. Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.
Active Comparator: BSPTS Exercise Group
Other: BSPTS Exercise
Participants will receive a Barcelona Scoliosis Physical Therapy School (BSPTS)-based scoliosis-specific exercise program. The program will include three-dimensional self-correction exercises focusing on spinal elongation, derotation, and sagittal plane alignment. Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Trunk Rotation Angle
Time Frame: Baseline and immediately after the 6-week intervention.
Trunk rotation angle measured using a scoliometer during the Adams Forward Bend Test.
Baseline and immediately after the 6-week intervention.
Core Muscle Endurance
Time Frame: Baseline and immediately after the 6-week intervention.
Core muscle endurance assessed using the McGill Core Endurance Test Battery, including trunk flexor, trunk extensor, and right and left lateral plank tests.
Baseline and immediately after the 6-week intervention.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Dynamic Balance
Time Frame: Baseline and immediately after the 6-week intervention.
Dynamic balance assessed using the Y-Balance Test.
Baseline and immediately after the 6-week intervention.
Spinal Appearance Perception
Time Frame: Baseline and immediately after the 6-week intervention.
Spinal appearance perception assessed using the Spinal Appearance Questionnaire (SAQ).
Baseline and immediately after the 6-week intervention.
Postural Awareness
Time Frame: Baseline and immediately after the 6-week intervention.
Postural awareness assessed using the Postural Awareness Scale (PAS).
Baseline and immediately after the 6-week intervention.
Scoliosis-Related Quality of Life
Time Frame: Baseline and immediately after the 6-week intervention.
Quality of life, functional status, and psychosocial impact assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire.
Baseline and immediately after the 6-week intervention.
Global Perceived Change
Time Frame: Immediately after the 6-week intervention.
Perceived change following treatment assessed using the Global Rating of Change Scale.
Immediately after the 6-week intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istinye University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 20, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 25, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 25, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 8, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 8, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 12, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 8, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 103

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings